50
Participants
Start Date
June 30, 2023
Primary Completion Date
March 18, 2025
Study Completion Date
April 11, 2025
NST-1024
400 mg BID
Placebo
matched placebo to active arm
Hatboro Medical Associates/ CCT Research, Hatboro
Mercado Medical Practice / CCT Research, Philadelphia
Velocity Clinical Research - Union, Union
Palmetto Clinical Reserach, Summerville
Lifeline Primary Care/ CCT Research, Lilburn
Velocity Clinical Research, New Smyrna Beach, Edgewater
Floridian Clinical Research, Miami Lakes
Metabolic Research Institute, Inc., West Palm Beach
Clearwater Cardiovascular Consultants, Largo
University of Alabama - Heersink School of Medicine, Birmingham
Alliance for Multispecialty Research, LLC (AMR) - Daphne, Daphne
University of Louisville - UoL Physicians Outpatient Center, Louisville
Velocity Clinical Research - Cleveland, Cleveland
Velocity Clinical Research - Cincinnati, Cincinnati
Velocity Clinical Research, Valparaiso, Valparaiso
Deaconess Clinic - Indiana, Evansville
Troy Internal Medicine, Troy
Clay Platte Family Medicine / CCT Research, Kansas City
Alliance for Multispecialty Research, LLC (AMR) - Newton, Newton
Velocity Clinical Research - Kearney, Lincoln
Apex Mobile Clinical Research, Bellaire
Pinnacle Clinical Research - San Antonio, San Antonio
Lynn Institute of Denver, Aurora
Velocity Clinical Research - Boise, Meridian
Velocity Clinical Research - Salt Lake City, Salt Lake City
Ogden Clinic, Mount View/CCT Research, Pleasant View
Alliance for Multispecialty Research, LLC (AMR) - Phoenix, Tempe
Velocity Clinical Research, North Hollywood, North Hollywood
Velocity Clinical Research, San Diego, La Mesa
Velocity Clinical Research - Costal Heart, Santa Ana
Cenexel HRI, Berlin
Lead Sponsor
NorthSea Therapeutics B.V.
INDUSTRY